Basic Info

10165 McKellar Court
San Diego, CA 92121
(800) 874-1517
  N/A
www.quidel.com
Preferred contact:
  Caren L Mason - President/CEO
Quidel Corporation
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Quidel Corporation develops, manufactures and markets point-of-care (POC) rapid diagnostic tests for the detection and management of medical conditions and illnesses. The Company's products provide healthcare professionals and consumers with accurate and cost-effective diagnostic information at the POC. The Company sells its products to professionals for use in physician offices, hospitals, clinical laboratories and wellness screening centers. The Company provides rapid POC diagnostic tests under the brand names QuickVue, QuickVue+, QuickVue Advance, OvuQuick, Conceive, CARDS, RapidVue, BlueTest, Metra, QUS-2, UrinQuick, RapiMat and FemExam. The Company's rapid POC diagnostic tests, biochemical bone markers and ultrasonometer participate in the following medical and wellness categories: pregnancy, group A strep and influenza detection, metabolic bone markers, Helicobacter pylori, urinalysis, other infectious disease products, ovulation QUS-2, bacterial vaginosis and other products.

 Synopsis: Awardee Business Condition
Year Founded 1979 IP Holdings 50-74
Employee Range 250-500 VC funded? Yes
Revenue Range Over 100M Private/Public Publicly Traded
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
2004 1 NIH $133,750 A High Accuracy Point-of-Care Chlamydia trachomatis Test

      

Media coverage